Cutler Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-800
Closed -$3K 2331
2023
Q4
$3K Sell
800
-2,600
-76% -$174K ﹤0.01% 2912
2023
Q3
$32K Buy
3,400
+2,400
+240% +$179K 0.01% 1729
2023
Q2
$12K Sell
1,000
-4,300
-81% -$317K ﹤0.01% 2134
2023
Q1
$21K Sell
5,300
-2,400
-31% -$158K ﹤0.01% 1885
2022
Q4
$29K Sell
7,700
-10,100
-57% -$604K ﹤0.01% 1951
2022
Q3
$371K Sell
17,800
-7,300
-29% -$365K 0.04% 670
2022
Q2
$360K Buy
25,100
+17,500
+230% +$553K 0.05% 682
2022
Q1
$326K Sell
7,600
-10,000
-57% -$310K 0.03% 890
2021
Q4
$484K Buy
17,600
+1,500
+9% +$55.2K 0.03% 764
2021
Q3
$547K Sell
16,100
-5,100
-24% -$199K 0.04% 742
2021
Q2
$310K Buy
21,200
+7,500
+55% +$450K 0.02% 1034
2021
Q1
$402K Buy
13,700
+1,700
+14% +$120K 0.03% 850
2020
Q4
$22K Buy
12,000
+1,400
+13% +$105K ﹤0.01% 2608
2020
Q3
$50K Buy
10,600
+1,100
+12% +$85.7K 0.01% 1790
2020
Q2
$48K Sell
9,500
-2,600
-21% -$200K 0.01% 1772
2020
Q1
$179K Sell
12,100
-2,900
-19% -$236K 0.02% 1014
2019
Q4
$15K Buy
15,000
+6,000
+67% +$242K ﹤0.01% 2385
2019
Q3
$47K Buy
+9,000
New +$231K 0.01% 1576
2019
Q2
Sell
-16,900
Closed -$2K 4240
2019
Q1
$2K Buy
+16,900
New +$157K ﹤0.01% 3330

Other funds holding AXSM